Page last updated: 2024-12-04

3-nitrosobenzamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID1679
CHEMBL ID28769
SCHEMBL ID1565391
MeSH IDM0204649

Synonyms (17)

Synonym
nsc-674195
144189-66-2
3-nitrosobenzamide
nsc674195
CHEMBL28769
AKOS006271625
unii-9jl5o473rb
nitrosobenzamide
benzamide, 3-nitroso-
9jl5o473rb ,
nsc 674195
3-nitrosobenzamide [mi]
SCHEMBL1565391
OZUBORKYZRYLSQ-UHFFFAOYSA-N
DTXSID50162642
3-nitrosobenzamide, analytical standard, for drug analysis
Q27272639

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"E-ras 20 tumorigenic malignant cells and CV-1 non-tumorigenic cells were treated with a drug combination of 4-iodo-3-nitrobenzamide (INO(2)BA) and buthionine sulfoximine (BSO)."( Anti-cancer action of 4-iodo-3-nitrobenzamide in combination with buthionine sulfoximine: inactivation of poly(ADP-ribose) polymerase and tumor glycolysis and the appearance of a poly(ADP-ribose) polymerase protease.
Bauer, PI; Buki, KG; Comstock, JA; Hakam, A; Kirsten, E; Kun, E; Mendeleyeva, J, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID81231Compound concentration that provides 50% cytoprotection on CEM-SS cells and HIV-1RF was measured using XTT assay.; No data1998Journal of medicinal chemistry, Apr-23, Volume: 41, Issue:9
Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
AID81232Compound concentration that provides 50% cytoprotection on PBMC cultures and HIV-1RF was measured using XTT assay.1998Journal of medicinal chemistry, Apr-23, Volume: 41, Issue:9
Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
AID81062CC50 reflects the drug concentration that elicits 50% cell death of PBMC cultures and HIV-1RF was measured using XTT assay.1998Journal of medicinal chemistry, Apr-23, Volume: 41, Issue:9
Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
AID235382Therapeutic index (EC50 / CC50) was evaluated; No data1998Journal of medicinal chemistry, Apr-23, Volume: 41, Issue:9
Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
AID81061CC50 reflects the drug concentration that elicits 50% cell death of CEM-SS cells and HIV-1RF was measured using XTT assay.1998Journal of medicinal chemistry, Apr-23, Volume: 41, Issue:9
Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's9 (75.00)18.2507
2000's1 (8.33)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.64 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]